Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:CSCI - Post by User

Comment by prophetoffactzon Aug 22, 2024 9:41pm
73 Views
Post# 36192844

RE:WHY NO INSIDER BUYER

RE:WHY NO INSIDER BUYERHopeforthebest believes that speculative microcap biopharma is a retirement plan and a guarentee to riches. Insiders near retirement should wildly bet it all on green he believes. The truth is that such stocks can be overwhelmed by many, many factors that have nothing to do with management. We've been in the worst biotech bear market in history. COVID and the associated interest rate and inflation shock has destroyed many biotech companies and led to catastrophic dilution. There can be economic crisis. CZO's main client was also spun-off and demand patterns suddenly changed leaving CZO at the bottom of the biotech bear market in need of cash for its next step. There can be changes in competition due to new science, etc. Demand for consumer products can also be very fickle and can be met with consumer boycotts, etc. We live in a cancel culture and companies can be seen as too woke. Jennifer Aniston recently got in a conflict with JD Vance after the childless cat lady comment. There are many scientific and regulatory risks. The diagnostic trial may not work out. PGX may take years longer to figure out. Drugs could fail. As a percentage of his overall wealth Gilles probably has too many shares. He's never sold a single share and has only added to his holdings over time. He's committed the most important professional years of his life to this company. They've invested the profits in the company's long term vision. The Canadian government has supported their plans. Pharma icon Ronnie Miller has committed his time. You need to be very well diversified given the risks here. Be humble before the many known and unkown risks or end up looking like a hyper-whiny bagholder like Hopeforthebest.    
<< Previous
Bullboard Posts
Next >>